Thank you for supporting MSK Giving Day!
MSK Giving Day is a celebration of how our community makes the impossible possible. Whether you’re a Fred’s Team runner, Cycle for Survival participant, or loyal supporter, you fund critical research and care at MSK.
Your support is revolutionizing cancer treatment and care
At any given time, MSK has nearly 2,000 clinical trials underway — each one with the potential to find the next breakthrough. The generosity of the MSK Giving community is helping revolutionize how cancer is diagnosed and treated around the world.
And together, we are making the impossible possible
- A groundbreaking rectal cancer immunotherapy clinical trial, in which 100% of participants saw their tumors disappear.
- The first new treatment in 20 years for people with low-grade glioma, a rare and aggressive form of brain cancer.
- A three-drug immunotherapy combination for ER+ and HER2 breast cancers that keeps the disease from progressing for more than twice as long.
Powering progress as a community
Each MSK Giving Day, people from almost every state donate to propel breakthroughs in critical areas of cancer research and care. Together, we are committed to doing even more.
Driving discovery
A clinical trial at MSK achieved a 100% remission rate for rectal cancer using the immunotherapy dostarlimab (Jemperli®). The treatment received FDA Breakthrough Therapy Designation last year, bringing it closer to those who need it.
Read the updateFast-tracking cures
Unique to MSK, our researchers and clinicians work side by side. This allows us to base our research on the most pressing challenges in patient care, and move promising discoveries from the lab to clinical trials faster.
Kevin Bartolotto, a mechanic and volunteer firefighter from Bayville, New York, runs with Fred’s Team to honor his late grandmother and support cancer research at MSK. He has raised over $82,000.
Kevin Bartolotto, a mechanic and volunteer firefighter from Bayville, New York, runs with Fred’s Team to honor his late grandmother and support cancer research at MSK. He has raised over $82,000.